Just stumbled upon this analyst, calls Geron a buy and 12 month forecast is double the current evaluation. Starts just before the 26 min mark and thinks Imetelstat can get to at least $1bill for lower-risk MDS alone. Hmmmm SNT- 5505 looking at High risk and low/intermediate.....
Ann: German MDS group awarded $2.5m grant for phase 2 MDS trial, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.003(4.76%) |
Mkt cap ! $97.55M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.6¢ | 6.0¢ | $154.2K | 2.423M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 273330 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 150000 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| SNT (ASX) Chart |